Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Perez

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Ebiomedicine|November 11, 2017
Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase InhibitorHuifeng Niu, Hyunjin Shin, Feng Gao, et al.
Frontiers in Oncology|June 9, 2023
Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice surveyKathryn A Mraz, Rachel Hodan, Linda Rodgers-Fouche, et al.
The Oncologist|January 21, 2025
A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumorsKimberly Perez, Matthew H Kulke, Hui Zheng, et al.
British Journal of Cancer|March 15, 2019
Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer riskTsuyoshi Hamada, Chen Yuan, Matthew B Yurgelun, et al.
Journal of the National Cancer Institute|March 19, 2021
Prediagnostic Inflammation and Pancreatic Cancer SurvivalChen Yuan, Vicente Morales-Oyarvide, Natalia Khalaf, et al.
British Journal of Cancer|May 19, 2023
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomasNitya Raj, Jennifer A Chan, Stephanie J Wang, et al.
Pancreas|May 3, 2021
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and ParagangliomaLauren Fishbein, Jaydira Del Rivero, Tobias Else, et al.
Clinical and Translational Gastroenterology|February 28, 2023
Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective CohortsAlice A Lee, Qiao-Li Wang, Jihye Kim, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 23, 2021
Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomesVishwajith Sridharan, Mari Mino-Kenudson, James M Cleary, et al.
Journal for Immunotherapy of Cancer|June 21, 2023
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humansVictoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Ebiomedicine|November 11, 2017
Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase InhibitorHuifeng Niu, Hyunjin Shin, Feng Gao, et al.
Frontiers in Oncology|June 9, 2023
Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice surveyKathryn A Mraz, Rachel Hodan, Linda Rodgers-Fouche, et al.
The Oncologist|January 21, 2025
A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumorsKimberly Perez, Matthew H Kulke, Hui Zheng, et al.
British Journal of Cancer|March 15, 2019
Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer riskTsuyoshi Hamada, Chen Yuan, Matthew B Yurgelun, et al.
Journal of the National Cancer Institute|March 19, 2021
Prediagnostic Inflammation and Pancreatic Cancer SurvivalChen Yuan, Vicente Morales-Oyarvide, Natalia Khalaf, et al.
British Journal of Cancer|May 19, 2023
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomasNitya Raj, Jennifer A Chan, Stephanie J Wang, et al.
Pancreas|May 3, 2021
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and ParagangliomaLauren Fishbein, Jaydira Del Rivero, Tobias Else, et al.
Clinical and Translational Gastroenterology|February 28, 2023
Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective CohortsAlice A Lee, Qiao-Li Wang, Jihye Kim, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 23, 2021
Pancreatic acinar cell carcinoma: A multi-center series on clinical characteristics and treatment outcomesVishwajith Sridharan, Mari Mino-Kenudson, James M Cleary, et al.
Journal for Immunotherapy of Cancer|June 21, 2023
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humansVictoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, et al.
Pageof 7